In preclinical studies involving various cancer models, including ESCC, overexpression of EGFR has been found to contribute to epithelial cell proliferation, differentiation, and migration [4,5] and had an inverse relationship to tumor radiocurability [6,7]. This evidence concerns the gene EGFR and neoplasm.